Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

Registrieren

TENX Tenax Therapeutics Inc

3,585

0,015 (0,42%)

11 Mai 2024 - Geschlossen

Verzögert um 15 Minuten

Form 424B3 - Prospectus [Rule 424(b)(3)]

null

Tenax Therapeutics (NASDAQ:TENX)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Tenax Therapeutics Charts.

Tenax Therapeutics (NASDAQ:TENX)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Tenax Therapeutics Charts.

News Tenax Therapeutics Inc

Tenax Therapeutics Announces New U.S. Patent Covering the Use of Levosimendan in Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF)
Dienstag 30 April 2024 (2 Wochen vor) • GlobeNewswire Inc.

Tenax Therapeutics to Host KOL Event: “LEVEL Setting: the Scientific Rationale for Levosimendan as a Potential First Treatment for PH-HFpEF, and the Ongoing Phase 3 LEVEL Study”
Dienstag 9 April 2024 (1 Monat vor) • GlobeNewswire Inc.

Tenax Therapeutics Provides Business and Clinical Development Updates with Full Year 2023 Financial Results
Donnerstag 28 März 2024 (1 Monat vor) • GlobeNewswire Inc.

Tenax Therapeutics to Present at the 36th Annual Roth Conference
Dienstag 12 März 2024 (2 Monate vor) • GlobeNewswire Inc.

Tenax Therapeutics Announces Oral Presentation of Levosimendan for the Treatment of PH-HFpEF at THT 2024
Donnerstag 29 Februar 2024 (2 Monate vor) • GlobeNewswire Inc.

Form 424B3 - Prospectus [Rule 424(b)(3)]
Montag 26 Februar 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Freitag 23 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Dienstag 20 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 20 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Tenax Therapeutics Announces Global License Amendment that Significantly Expands Rights to Levosimendan
Dienstag 20 Februar 2024 (3 Monate vor) • GlobeNewswire Inc.

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Freitag 16 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Freitag 16 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Weitere Tenax Therapeutics Inc News-Artikel

Euro vs Sterling

Euro vs US Dollar

Gold vs US Dollar

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen